News items related to: Gilead
-
Ending the Epidemic Could Cost Under $40 (per person, per year) – treatment activists say at AIDS2024
Munich, 23 July 2024 – Despite global efforts to end HIV and AIDS, the epidemic has been persistent. In 2022,...
-
Samarn: Activists fought for my right to survive – and won
“Back in 1994, when I was in my early 20s, I fell ill while doing construction work in Bangkok. That’s...
-
Thailand’s opposition against Gilead’s patent application: overcharging what?
Earlier this month, Thai civil society opposed Gilead’s Sciences’ patent application on remdesivir, which has been trialled in the treatment...
